194 related articles for article (PubMed ID: 21258365)
1. In situ mass spectrometry of autoimmune liver diseases.
Bowlus CL; Seeley EH; Roder J; Grigorieva J; Roder H; Caprioli RM; Gershwin M
Cell Mol Immunol; 2011 May; 8(3):237-42. PubMed ID: 21258365
[TBL] [Abstract][Full Text] [Related]
2. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
3. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
4. Autoimmune hepatitis and overlap syndromes.
Dienes HP; Erberich H; Dries V; Schirmacher P; Lohse A
Clin Liver Dis; 2002 May; 6(2):349-62, vi. PubMed ID: 12122860
[TBL] [Abstract][Full Text] [Related]
5. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis.
Chung BK; Guevel BT; Reynolds GM; Gupta Udatha DB; Henriksen EK; Stamataki Z; Hirschfield GM; Karlsen TH; Liaskou E
J Autoimmun; 2017 Feb; 77():45-54. PubMed ID: 27784538
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of autoantibodies to p53 protein in patients with autoimmune liver diseases.
Himoto T; Yoneyama H; Kurokohchi K; Inukai M; Masugata H; Goda F; Haba R; Watanabe S; Senda S; Masaki T
Can J Gastroenterol; 2012 Mar; 26(3):125-9. PubMed ID: 22408762
[TBL] [Abstract][Full Text] [Related]
7. High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6.
Xu B; Broome U; Ericzon BG; Sumitran-Holgersson S
Gut; 2002 Jul; 51(1):120-7. PubMed ID: 12077104
[TBL] [Abstract][Full Text] [Related]
8. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.
Boberg KM; Aadland E; Jahnsen J; Raknerud N; Stiris M; Bell H
Scand J Gastroenterol; 1998 Jan; 33(1):99-103. PubMed ID: 9489916
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease.
Moreira RK; Revetta F; Koehler E; Washington MK
World J Gastroenterol; 2010 Jan; 16(4):453-7. PubMed ID: 20101770
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune liver serology: current diagnostic and clinical challenges.
Bogdanos DP; Invernizzi P; Mackay IR; Vergani D
World J Gastroenterol; 2008 Jun; 14(21):3374-87. PubMed ID: 18528935
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance.
Sebode M; Weiler-Normann C; Liwinski T; Schramm C
Front Immunol; 2018; 9():609. PubMed ID: 29636752
[TBL] [Abstract][Full Text] [Related]
12. Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases.
Terjung B; Spengler U
Clin Rev Allergy Immunol; 2005 Apr; 28(2):115-33. PubMed ID: 15879618
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G; Riva S; Sciveres M
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
[TBL] [Abstract][Full Text] [Related]
14. The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview.
Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D
J Autoimmun; 2018 Dec; 95():144-158. PubMed ID: 30366656
[TBL] [Abstract][Full Text] [Related]
15. Overlap syndromes among autoimmune liver diseases.
Rust C; Beuers U
World J Gastroenterol; 2008 Jun; 14(21):3368-73. PubMed ID: 18528934
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
Nguyen HH; Shaheen AA; Baeza N; Lytvyak E; Urbanski SJ; Mason AL; Norman GL; Fritzler MJ; Swain MG
PLoS One; 2018; 13(3):e0193960. PubMed ID: 29554146
[TBL] [Abstract][Full Text] [Related]
17. The role of complement activation in autoimmune liver disease.
Biewenga M; Farina Sarasqueta A; Tushuizen ME; de Jonge-Muller ESM; van Hoek B; Trouw LA
Autoimmun Rev; 2020 Jun; 19(6):102534. PubMed ID: 32234403
[TBL] [Abstract][Full Text] [Related]
18. Portal tract eosinophils and hepatocyte cytokeratin 7 immunoreactivity helps distinguish early-stage, mildly active primary biliary cirrhosis and autoimmune hepatitis.
Goldstein NS; Soman A; Gordon SC
Am J Clin Pathol; 2001 Dec; 116(6):846-53. PubMed ID: 11764073
[TBL] [Abstract][Full Text] [Related]
19. Overlap Syndromes.
Chazouillères O
Dig Dis; 2015; 33 Suppl 2():181-7. PubMed ID: 26641819
[TBL] [Abstract][Full Text] [Related]
20. Overlap syndromes of cholestatic liver diseases and auto-immune hepatitis.
Schramm C; Lohse AW
Clin Rev Allergy Immunol; 2005 Apr; 28(2):105-14. PubMed ID: 15879617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
